Franklin E. Roth

658 total citations
22 papers, 501 citations indexed

About

Franklin E. Roth is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, Franklin E. Roth has authored 22 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 6 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Franklin E. Roth's work include Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), Respiratory and Cough-Related Research (2 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Franklin E. Roth is often cited by papers focused on Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), Respiratory and Cough-Related Research (2 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Franklin E. Roth collaborates with scholars based in United States. Franklin E. Roth's co-authors include Alan A. Rubin, Richard M. Taylor, Martin M. Winbury, John G. Topliss, Nathan Sperber, Robert I. Taber, Margaret H. Sherlock, A Barnett, I.I.A. Tabachnick and S. Tozzi and has published in prestigious journals such as Nature, Science and Circulation Research.

In The Last Decade

Franklin E. Roth

22 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franklin E. Roth United States 13 130 88 84 74 52 22 501
Alan A. Rubin United States 10 128 1.0× 67 0.8× 65 0.8× 68 0.9× 35 0.7× 23 473
Morton E. Goldberg United States 9 218 1.7× 38 0.4× 51 0.6× 149 2.0× 140 2.7× 15 584
Martin M. Winbury United States 15 164 1.3× 48 0.5× 178 2.1× 418 5.6× 27 0.5× 47 846
N. N. Share Canada 14 139 1.1× 51 0.6× 162 1.9× 65 0.9× 115 2.2× 33 541
John M. Stavorski United States 11 219 1.7× 65 0.7× 132 1.6× 53 0.7× 200 3.8× 16 593
Herbert C. Wenger United States 10 263 2.0× 47 0.5× 130 1.5× 132 1.8× 225 4.3× 18 659
J. H. Trapold United States 9 60 0.5× 46 0.5× 35 0.4× 31 0.4× 51 1.0× 10 308
Hilma S. Alpers United States 12 200 1.5× 37 0.4× 69 0.8× 33 0.4× 176 3.4× 17 457
A. A. Renzi United States 12 71 0.5× 41 0.5× 52 0.6× 22 0.3× 28 0.5× 38 451
AM Wilson United Kingdom 12 166 1.3× 37 0.4× 70 0.8× 80 1.1× 119 2.3× 27 442

Countries citing papers authored by Franklin E. Roth

Since Specialization
Citations

This map shows the geographic impact of Franklin E. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franklin E. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franklin E. Roth more than expected).

Fields of papers citing papers by Franklin E. Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franklin E. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franklin E. Roth. The network helps show where Franklin E. Roth may publish in the future.

Co-authorship network of co-authors of Franklin E. Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Franklin E. Roth. A scholar is included among the top collaborators of Franklin E. Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franklin E. Roth. Franklin E. Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tozzi, S., Franklin E. Roth, & I.I.A. Tabachnick. (1974). The pharmacology of azatadine, a potential antiallergy drug. Inflammation Research. 4(4). 264–270. 34 indexed citations
2.
Roth, Franklin E., et al.. (1968). MECHANISM OF THE ANTIHYPERTENSIVE EFFECT OF DIAZOXIDE: IN VITRO VASCULAR STUDIES IN THE HYPERTENSIVE RAT. Journal of Pharmacology and Experimental Therapeutics. 162(1). 109–114. 14 indexed citations
3.
Taber, Robert I., et al.. (1968). Comparison of perphenazine and fluphenazine enanthates in rats. Psychopharmacology. 12(5). 441–447. 13 indexed citations
4.
Roth, Franklin E., et al.. (1968). The role of calcium in the mechanism of the antihypertensive action of diazoxide. Life Sciences. 7(7). 381–387. 13 indexed citations
5.
Roth, Franklin E., et al.. (1967). STUDIES ON THE MECHANISM OF ANTIHYPERTENSIVE ACTION OF DIAZOXIDE: IN VITRO VASCULAR PHARMACODYNAMICS. Journal of Pharmacology and Experimental Therapeutics. 158(3). 531–539. 50 indexed citations
6.
Topliss, John G., et al.. (1964). Antihypertensive Agents. II.1 3-Substituted 2H-1,2,4-Benzothiadiazine 1,1-Dioxides. Journal of Medicinal Chemistry. 7(3). 269–273. 13 indexed citations
7.
Topliss, John G., et al.. (1964). Antihypertensive Agents. III.1 3-Hydroxy-3-phenylphthalimidines. Journal of Medicinal Chemistry. 7(4). 453–456. 27 indexed citations
8.
Rubin, Alan A., et al.. (1962). PHARMACOLOGY OF DIAZOXIDE, AN ANTIHYPERTENSIVE, NONDIURETIC BENZOTHIADIAZINE. Journal of Pharmacology and Experimental Therapeutics. 136(3). 344–352. 96 indexed citations
9.
Rubin, Alan A., Franklin E. Roth, Martin M. Winbury, et al.. (1961). New Class of Antihypertensive Agents. Science. 133(3470). 2067–2067. 45 indexed citations
10.
Rubin, Alan A., Franklin E. Roth, Martin M. Winbury, et al.. (1961). New Class of Antihypertensive Agents. Science. 133(3470). 2067–2067. 55 indexed citations
11.
Rubin, Alan A., Franklin E. Roth, Martin M. Winbury, et al.. (1961). New Class of Antihypertensive Agents. Science. 133(3470). 2067–2067. 4 indexed citations
12.
Roth, Franklin E.. (1961). Antihistamine Activity of the Optical Isomers of Pheniramine and its Chlor- and Brom-Substituted Derivatives. Chemotherapy. 3(2). 120–127. 11 indexed citations
13.
Rubin, Alan A., Franklin E. Roth, & Martin M. Winbury. (1961). A Non-diuretic Benzothiadiazine with Anti-hypertensive Properties. Nature. 192(4798). 176–177. 26 indexed citations
14.
Tabachnick, I.I.A., et al.. (1958). ENZYMIC AND PHARMACOLOGIC COMPARISON OF IMIDAZOLEACETYLCHOLINE WITH TWO RELATED CHOLINE ESTERS, MUREXINE AND DIHYDROMUREXINE. Journal of Pharmacology and Experimental Therapeutics. 123(2). 98–103. 1 indexed citations
15.
Roth, Franklin E., et al.. (1958). Perphenazine (Trilafon) and Chlorpromazine in Experimental Shock.. Experimental Biology and Medicine. 99(1). 157–160. 1 indexed citations
16.
Roth, Franklin E., et al.. (1958). COMPARATIVE PHARMACOLOGY OF CHLORPHENIRAMINE (CHLOR-TRIMETON) AND ITS OPTICAL ISOMERS. Journal of Pharmacology and Experimental Therapeutics. 124(4). 347–349. 39 indexed citations
17.
Roth, Franklin E., et al.. (1957). HYDROXYPROPYL THEOPHYLLINE: A PHARMACOLOGICAL COMPARISON WITH OTHER THEOPHYLLINE PREPARATIONS. Journal of Pharmacology and Experimental Therapeutics. 121(4). 487–500. 5 indexed citations
18.
Tabachnick, I.I.A. & Franklin E. Roth. (1957). THE POTENTIATION OF HISTAMINE BY IMIDAZOLEACRYL-CHOLINE (MUREXINE) AND IMIDAZOLEPROPIONYL-CHOLINE (DIHYDROMUREXINE). Journal of Pharmacology and Experimental Therapeutics. 121(2). 191–198. 2 indexed citations
19.
Spellman, Mitchell W., et al.. (1955). Effects of somatotropic hormone (STH) and saline on mice exposed to total-body irradiation. Cancer. 8(1). 172–178. 1 indexed citations
20.
Roth, Franklin E. & C. Walton Lillehei. (1954). Effect of Growth Hormone upon Body Weight and Incidence of Bacterial Endocarditis in Rats Exposed to Hypoxia. Circulation Research. 2(3). 209–213. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan A. Rubin Breakdown of academic impact, for papers by Morton E. Goldberg Breakdown of academic impact, for papers by Martin M. Winbury Breakdown of academic impact, for papers by N. N. Share Breakdown of academic impact, for papers by John M. Stavorski Breakdown of academic impact, for papers by Herbert C. Wenger Breakdown of academic impact, for papers by J. H. Trapold Breakdown of academic impact, for papers by Hilma S. Alpers Breakdown of academic impact, for papers by A. A. Renzi Breakdown of academic impact, for papers by AM Wilson
Rankless by CCL
2026